search
Back to results

Study of the PAS-Port® Proximal Anastomosis System in Coronary Bypass Surgery (EPIC)

Primary Purpose

Coronary Artery Disease

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
PAS-Port Automated Proximal Anastomosis System
Sponsored by
Cardica, Inc
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Coronary Artery Disease

Eligibility Criteria

50 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

PRE-OPERATIVELY Inclusion Criteria: Able to give informed consent, able to understand the intent and clinical meaning of the study as well as its implications. Patient is legally competent. Assessment that the patient is willing and able to have follow-up visits and examinations Age greater than or equal to 50 years and less than 85 years Ejection fraction of >30% Can tolerate radiographic contrast media Requires non-emergent coronary artery bypass with at least two vein bypass grafts intended Coronary artery targets intended for bypass index grafts must have >70% native stenosis Life expectancy >1 year Exclusion Criteria: Patient is participating in other clinical trials that would conflict with this protocol Unable to meet study requirements (travel, general health) Pregnancy Previous cardiac surgery Requiring preoperative use of an intraaortic balloon pump Congestive heart failure / NYHA Class IV History of thromboembolic disease requiring ongoing anticoagulation therapy or the presence of a bleeding disorder Acute or chronic dialysis Creatinine of greater than 200 µmol/L (2.3 mg/dL) in the last 30 days Documented acute or suspected systemic infection Need for ongoing immunosuppressive therapy Recent (less than 2 weeks) history of cerebrovascular accident Aspirin allergy or other contraindications to aspirin use INTRA-OPERATIVELY Inclusion Criteria: Patient is hemodynamically stable Open chest reassessment of the revascularization strategy confirms that two vein bypass grafts are still intended Target vessel wall properties that are suitable for performing both a hand-sewn and a PAS-Port anastomosis Target vessel is greater than 1.8 mm in diameter at sites where anastomoses are planned Target vessel at sites where anastomoses will be placed are free from severe calcifications or severe atheromas The length of the vein graft(s) is adequate for both of the planned index graft revascularization strategies Vein outside diameter and double wall thickness are between 4 and 6 mm(inclusive) and less than or equal to 1.4 mm, respectively, at the graft site intended for the PAS-Port proximal anastomosis The vein(s) is of suitable quality to be used as a bypass graft conduit Exclusion Criteria: -Any of the Intra-operative Inclusion Criteria not met

Sites / Locations

  • St. Michael's Medical Center

Outcomes

Primary Outcome Measures

Effectiveness: Graft Patency at 9 months post-operatively
Safety: Peri-and Post-operative MACE and SAE

Secondary Outcome Measures

Full Information

First Posted
July 21, 2006
Last Updated
January 8, 2009
Sponsor
Cardica, Inc
search

1. Study Identification

Unique Protocol Identification Number
NCT00355563
Brief Title
Study of the PAS-Port® Proximal Anastomosis System in Coronary Bypass Surgery
Acronym
EPIC
Official Title
Use of the PAS-Port Proximal Anastomosis System for Creation of Aorto-Venous Proximal Anastomoses in Coronary Bypass Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
January 2009
Overall Recruitment Status
Completed
Study Start Date
June 2006 (undefined)
Primary Completion Date
December 2007 (Actual)
Study Completion Date
April 2008 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Cardica, Inc

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The study has been designed to comparatively evaluate the safety and effectiveness of the PAS-Port Proximal Anastomosis System and conventional suturing techniques for creation of the connection between graft veins and the aorta in patients undergoing coronary artery bypass graft surgery for treatment of coronary artery disease. Patients in the study will have a coronary angiogram approximately 9 months following surgery to determine the patency of vein grafts created using either the automated PAS-Port or hand sewn methods. Safety will be evaluated by documenting the occurence of adverse clinical events and evealuating possible association with either method.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
Single
Allocation
Randomized
Enrollment
220 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
PAS-Port Automated Proximal Anastomosis System
Primary Outcome Measure Information:
Title
Effectiveness: Graft Patency at 9 months post-operatively
Title
Safety: Peri-and Post-operative MACE and SAE

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
PRE-OPERATIVELY Inclusion Criteria: Able to give informed consent, able to understand the intent and clinical meaning of the study as well as its implications. Patient is legally competent. Assessment that the patient is willing and able to have follow-up visits and examinations Age greater than or equal to 50 years and less than 85 years Ejection fraction of >30% Can tolerate radiographic contrast media Requires non-emergent coronary artery bypass with at least two vein bypass grafts intended Coronary artery targets intended for bypass index grafts must have >70% native stenosis Life expectancy >1 year Exclusion Criteria: Patient is participating in other clinical trials that would conflict with this protocol Unable to meet study requirements (travel, general health) Pregnancy Previous cardiac surgery Requiring preoperative use of an intraaortic balloon pump Congestive heart failure / NYHA Class IV History of thromboembolic disease requiring ongoing anticoagulation therapy or the presence of a bleeding disorder Acute or chronic dialysis Creatinine of greater than 200 µmol/L (2.3 mg/dL) in the last 30 days Documented acute or suspected systemic infection Need for ongoing immunosuppressive therapy Recent (less than 2 weeks) history of cerebrovascular accident Aspirin allergy or other contraindications to aspirin use INTRA-OPERATIVELY Inclusion Criteria: Patient is hemodynamically stable Open chest reassessment of the revascularization strategy confirms that two vein bypass grafts are still intended Target vessel wall properties that are suitable for performing both a hand-sewn and a PAS-Port anastomosis Target vessel is greater than 1.8 mm in diameter at sites where anastomoses are planned Target vessel at sites where anastomoses will be placed are free from severe calcifications or severe atheromas The length of the vein graft(s) is adequate for both of the planned index graft revascularization strategies Vein outside diameter and double wall thickness are between 4 and 6 mm(inclusive) and less than or equal to 1.4 mm, respectively, at the graft site intended for the PAS-Port proximal anastomosis The vein(s) is of suitable quality to be used as a bypass graft conduit Exclusion Criteria: -Any of the Intra-operative Inclusion Criteria not met
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John Puskas, M.D.
Organizational Affiliation
Emory University
Official's Role
Principal Investigator
Facility Information:
Facility Name
St. Michael's Medical Center
City
Newark
State/Province
New Jersey
ZIP/Postal Code
07102
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Study of the PAS-Port® Proximal Anastomosis System in Coronary Bypass Surgery

We'll reach out to this number within 24 hrs